Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Jump To

Eloctate Dosage

Generic name: antihemophilic factor (recombinant)
Brand names: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Esperoct
Drug class: Miscellaneous coagulation modifiers

Medically reviewed by  A Ras MD.

 

Recommended Adult Dosing

Dosage forms:  INJ

Hemophilia A

[bleeding episode, minor-moderate]
Dose: individualize dose IV q24-48h until hemostasis; Info: estimated dose (units) is [wt (kg) x desired factor VIII level (%) x 0.5] where desired factor VIII level 40-60%
[bleeding episode, major]
Dose: individualize dose IV q12-24h until hemostasis; Info: estimated dose (units) is [wt (kg) x desired factor VIII level (%) x 0.5] where desired factor VIII level 80-100%
[bleeding prophylaxis, minor surgery]
Dose: individualize dose IV x1 preop, then repeat dose IV q24h for at least 1 day until healing complete; Info: estimated dose (units) is [wt (kg) x desired factor VIII level (%) x 0.5] where desired factor VIII level 50-80%
[bleeding prophylaxis, major surgery]
Dose: 40-60 units/kg/dose IV x1 preop, then 40-50 units/kg/dose IV x1 8-24h postop, then repeat dose IV q24h for at least 7 days after healing complete; Info: desired factor VIII level 80-120%
[routine bleeding prophylaxis]
Dose: 25-65 units/kg/dose IV q3-5 days; Start: 50 units/kg/dose IV q4 days

Renal dosing

[not defined]
renal impairment: not defined
HD/PD: not defined

Hepatic dosing

[not defined]

Recommended Peds Dosing

Dosage forms:  INJ

Hemophilia A

[bleeding episode, minor-moderate, 2-5 yo]
Dose: individualize dose IV q12-24h until hemostasis; Info: estimated dose (units) is [wt (kg) x desired factor VIII level (%) x 0.5] where desired factor VIII level 40-60%
[bleeding episode, minor-moderate, 6 yo and older]
Dose: individualize dose IV q24-48h until hemostasis; Info: estimated dose (units) is [wt (kg) x desired factor VIII level (%) x 0.5] where desired factor VIII level 40-60%
[bleeding episode, major, 2-5 yo]
Dose: individualize dose IV q8-24h until hemostasis; Info: estimated dose (units) is [wt (kg) x desired factor VIII level (%) x 0.5] where desired factor VIII level 80-100%
[bleeding episode, major, 6 yo and older]
Dose: individualize dose IV q12-24h until hemostasis; Info: estimated dose (units) is [wt (kg) x desired factor VIII level (%) x 0.5] where desired factor VIII level 80-100%
[bleeding prophylaxis, minor surgery, 2-5 yo]
Dose: individualize dose IV x1 preop, then repeat dose IV q12-24h for at least 1 day until healing complete; Info: estimated dose (units) is [wt (kg) x desired factor VIII level (%) x 0.5] where desired factor VIII level 50-80%
[bleeding prophylaxis, minor surgery, 6 yo and older]
Dose: individualize dose IV x1 preop, then repeat dose IV q24h for at least 1 day until healing complete; Info: estimated dose (units) is [wt (kg) x desired factor VIII level (%) x 0.5] where desired factor VIII level 50-80%
[bleeding prophylaxis, major surgery, 2-5 yo]
Dose: 40-60 units/kg/dose IV x1 preop, then 40-50 units/kg/dose IV x1 6-24h postop, then repeat dose IV q24h for at least 7 days after healing complete; Info: desired factor VIII level 80-120%
[bleeding prophylaxis, major surgery, 6 yo and older]
Dose: 40-60 units/kg/dose IV x1 preop, then 40-50 units/kg/dose IV x1 8-24h postop, then repeat dose IV q24h for at least 7 days after healing complete; Info: desired factor VIII level 80-120%
[routine bleeding prophylaxis]
Dose: 25-65 units/kg/dose IV q3-5 days; Start: 50 units/kg/dose IV q4 days; Info: more frequent or higher doses up to 80 units/kg/dose may be required for pts <6 yo

Renal dosing

[not defined]
renal impairment: not defined
HD/PD: not defined

Hepatic dosing

[not defined]

 

SRC: NLM .

Read Next Article